Leptin is associated with increased risk of myocardial infarction

Abstract. Söderberg S, Ahrén B, Jansson J‐H, Johnson O, Hallmans G, Asplund K, Olsson T (Umeå University, Umeå; and Lund University, Malmö, Sweden). Leptin is associated with increased risk of myocardial infarction. J Intern Med 1999; 246: 409–418.

[1]  T. Meade,et al.  Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study , 1993, The Lancet.

[2]  G. Bray,et al.  Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1997 by The Endocrine Society CLINICAL REVIEW 90 Leptin and Clinical Medicine: A New Piece in the Puzzle , 2022 .

[3]  R. Considine,et al.  Leptin: The Tale of an Obesity Gene , 1996, Diabetes.

[4]  K. Polonsky,et al.  Abnormalities of insulin pulsatility and glucose oscillations during meals in obese noninsulin-dependent diabetic patients: effects of weight reduction. , 1996, The Journal of clinical endocrinology and metabolism.

[5]  G. Dagenais,et al.  Leptinemia Is Not a Risk Factor for Ischemic Heart Disease in Men: Prospective results from the Quebec Cardiovascular Study , 1998, Diabetes Care.

[6]  B. Stegmayr,et al.  Measuring stroke in the population: quality of routine statistics in comparison with a population-based stroke registry. , 1992, Neuroepidemiology.

[7]  H. Tunstall-Pedoe,et al.  Myocardial Infarction and Coronary Deaths in the World Health Organization MONICA Project: Registration Procedures, Event Rates, and Case‐Fatality Rates in 38 Populations From 21 Countries in Four Continents , 1994, Circulation.

[8]  G. Bray.  An approach to the classification and evaluation of obesity. , 1992 .

[9]  G. Frühbeck.  Pivotal role of nitric oxide in the control of blood pressure after leptin administration. , 1999, Diabetes.

[10]  M. Laakso,et al.  Leptin concentrations and insulin sensitivity in normoglycemic men , 1997, International Journal of Obesity.

[11]  J. Hall,et al.  Chronic leptin infusion increases arterial pressure. , 1998, Hypertension.

[12]  S. Haffner,et al.  Epidemiology of hypertension and insulin resistance syndrome. , 1997, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[13]  P. Zimmet,et al.  Hyperleptinaemia: the Missing Link in the Metabolic Syndrome? , 1997, Diabetic medicine : a journal of the British Diabetic Association.

[14]  I. Brännström.  Community participation and social patterning in cardiovascular disease intervention , 1993 .

[15]  Huiqing Lu,et al.  Intracerebroventricular Leptin Increases Lumbar and Renal Sympathetic Nerve Activity and Blood Pressure in Normal Rats , 1997, Diabetes.

[16]  G M Steil,et al.  Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1998 by The Endocrine Society Diurnal and Ultradian Rhythmicity of Plasma Leptin: Effects of Gender and Adiposity* , 2022 .

[17]  A. Mark,et al.  Sympathetic and cardiorenal actions of leptin. , 1997, Hypertension.

[18]  R. Devos,et al.  Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. , 1995, Science.

[19]  I. Holme,et al.  Apolipoprotein B and A-I in relation to serum cholesterol and triglycerides in 43 000 Swedish males and females , 1992, International journal of clinical & laboratory research.

[20]  D. Porte,et al.  Cerebrospinal fluid leptin levels: Relationship to plasma levels and to adiposity in humans , 1996, Nature Medicine.

[21]  K. Polonsky,et al.  Modulation of glucose regulation and insulin secretion by circadian rhythmicity and sleep. , 1991, The Journal of clinical investigation.

[22]  Boman,et al.  Perceived health modifies the effect of biomedical risk factors in the prediction of acute myocardial infarction. An incident case–control study from northern Sweden , 1998, Journal of internal medicine.

[23]  G. Reaven.  Role of Insulin Resistance in Human Disease , 1988, Diabetes.

[24]  H. Tunstall-Pedoe,et al.  The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration , 1988 .

[25]  J. Ohannesian,et al.  Nocturnal rise of leptin in lean, obese, and non-insulin-dependent diabetes mellitus subjects. , 1996, The Journal of clinical investigation.

[26]  I. Godsland,et al.  Hyperleptinemia as a component of a metabolic syndrome of cardiovascular risk. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[27]  Principal Investigators,et al.  The World Health Organization MONICA project (monitoring trends and determinants in cardiovascular disease): a major international collabaration , 1988 .

[28]  R. Seeley,et al.  Neuroendocrine Responses to Starvation and Weight Loss , 1997 .

[29]  G. Reaven,et al.  Hypertension and associated metabolic abnormalities--the role of insulin resistance and the sympathoadrenal system. , 1996, The New England journal of medicine.

[30]  R. Considine,et al.  Serum immunoreactive-leptin concentrations in normal-weight and obese humans. , 1996, The New England journal of medicine.

[31]  M. Maffei,et al.  Positional cloning of the mouse obese gene and its human homologue , 1995, Nature.

[32]  R. Weindruch,et al.  Seminars in medicine of the Beth Israel Deaconess Medical Center. Caloric intake and aging. , 1997, The New England journal of medicine.

[33]  G. Cazzolato,et al.  ARE APOLIPOPROTEINS BETTER DISCRIMINATORS THAN LIPIDS FOR ATHEROSCLEROSIS? , 1979, The Lancet.

[34]  J. Blangero,et al.  Serum leptin levels are independently correlated with two measures of HDL. , 1997, Atherosclerosis.

[35]  T. Olsson,et al.  Plasma leptin levels are associated with abnormal fibrinolysis in men and postmenopausal women , 1999, Journal of internal medicine.

[36]  G. Westman,et al.  Reduction of selection bias in primary prevention of cardiovascular disease through involvement of primary health care. , 1998, Scandinavian journal of primary health care.

[37]  J. Mann,et al.  Apoproteins: predictors of coronary heart disease? , 1986, British medical journal.

[38]  A. Mark,et al.  Receptor-mediated regional sympathetic nerve activation by leptin. , 1997, The Journal of clinical investigation.

[39]  G. Reaven,et al.  Pathophysiology of insulin resistance in human disease. , 1995, Physiological reviews.

[40]  L. Weinehall,et al.  Leptin is a risk marker for first-ever hemorrhagic stroke in a population-based cohort. , 1999, Stroke.

[41]  M. Kornitzer,et al.  The World Health Organization MONICA Project (Monitoring trends and determinants in cardiovascular disease): A major international Collaboration , 1988 .

[42]  M. Maffei,et al.  Positional cloning of the mouse obese gene and its human homologue , 1994, Nature.

[43]  G. Mancia,et al.  Body weight reduction, sympathetic nerve traffic, and arterial baroreflex in obese normotensive humans. , 1998, Circulation.

[44]  G. Steil,et al.  Physiological insulinemia acutely modulates plasma leptin. , 1998, Diabetes.